Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
IslandWatch Newsletter
Contact
Contact Us
Subscribe for Email Alerts
Media
Media
>
News
News
IslandWatch Newsletter
News
Filter by Year:
2024
2023
2022
2021
2020
22-Dec-2023
Island Pharmaceuticals kicks off dosing for third cohort of ISLA-101 single ascending dose study for dengue treatment
15-Dec-2023
Island Pharmaceuticals secures loan facility with Radium Capital based on forecast R&D tax incentive claim
12-Dec-2023
Island Pharmaceuticals doses second cohort of subjects in ISLA-101 Single Ascending Dose study
5-Dec-2023
Island MD David Foster speaks to Bulls N' Bears about ISLA-101 and more
1-Dec-2023
Island Pharmaceuticals appoints new joint company secretary
24-Nov-2023
Island Pharmaceuticals kicks off "critical" study in Dengue fight
22-Nov-2023
Island Pharma one step closer to ISLA-101 dosing
16-Nov-2023
Island Pharmaceuticals gets ready to tackle mosquito-borne diseases as warmer climate accelerates spread
12-Nov-2023
Island Pharmaceuticals initiates screening for ISLA-101 study to combat mosquito-borne disease
10-Nov-2023
Island Pharmaceuticals nets over $300,000 in R&D tax refund
1
2
3
Next
.png){kind=logo}
